Mark Mortenson Buys 45,000 Shares of CLNN
CLNN's Chief Science Officer acquired 45,000 shares, reflecting insider confidence.
Key Points
- Mark Mortenson, Chief Science Officer of CLNN, bought 45,000 shares on June 11, 2026, at no cost per share.
- CLNN shares traded at around $5.78, with several institutional investors adjusting their positions.
- Analysts from HC Wainwright & Co. and D. Boral Capital reiterated buy ratings with targets of $31 and $23.
Important disclosure: Podchat is not a registered investment adviser, broker-dealer, or financial planner. This article is for informational and educational purposes only and is not a recommendation to buy, sell, or hold any security. Content may be generated by automated systems using public filings, market data, and third-party sources, and may contain errors or omissions. Investing involves risk, including possible loss of principal. Past performance, insider activity, analyst ratings, price targets, sentiment scores, and hypothetical or backtested results are not guarantees of future performance. Please do your own research and consult a qualified professional before making investment decisions.
On June 11, 2026, Mark Mortenson, the Chief Science Officer at CLNN, purchased 45,000 shares of the company. The transaction was recorded at no cost per share, indicating a non-cash arrangement. This move comes as part of a broader insider buying trend within the company.
Other Institutional Activity in CLNN
Several institutional investors have recently adjusted their positions in CLNN. Boxer Capital Management, LLC increased its holdings by 277,778 shares, ending with 477,515 shares valued at about $2.35 million. In contrast, Symbiosis Capital Partners, LLC reduced its stake by 339,401 shares, now holding 431,094 shares worth approximately $2.13 million. Vanguard Capital Management LLC initiated a new position with 308,230 shares valued at roughly $1.52 million. Scoggin Management LP added 25,000 shares, bringing its total to 300,000 shares valued at $1.48 million. Ensign Peak Advisors, Inc also increased its holdings significantly by 143,511 shares, reaching a total of 257,872 shares worth about $1.27 million.
Clene Inc. Stock Up 36.6%
Shares of CLNN traded at approximately $5.78 recently. The stock has seen several institutional changes, reflecting varied investor sentiment. The stock's performance and insider activity may influence market perceptions moving forward.
Insider Buying and Selling at Clene Inc.
In addition to Mark Mortenson's acquisition, CLNN saw other insiders purchasing shares. On June 11, 2026, Chief Financial Officer Brown Morgan bought 15,000 shares, President & CEO Robert Dee Etherington acquired 65,000 shares, and others made smaller purchases in late May. These transactions were not part of any pre-planned trading programs, suggesting strong insider confidence in the company's future.
Analysts Set New Price Targets
Analysts have shown optimism about CLNN's prospects. On May 4, 2026, HC Wainwright & Co. reiterated a buy rating with a price target of $31. Similarly, D. Boral Capital maintained its buy rating with a $23 target. These positive assessments could influence investor sentiment, supporting potential stock price growth.
Bottom Line
Mark Mortenson's purchase of 45,000 shares of CLNN underscores insider confidence in the company's future. This transaction, alongside other insider buys and institutional activity, suggests varied sentiment in the market. While analysts remain optimistic, with reiterated buy ratings and substantial price targets, investors will watch closely for continued performance and strategic developments.
Get Clene Inc. alerts
New 13F filings, insider trades, and analyst moves on $CLNN, sent to your inbox. Free, and you can unsubscribe anytime.
This instant news alert was generated by automated narrative technology and financial data from Podchat and public regulatory filings. It is for informational purposes only and is not financial advice.